Jishi Wang

Guizhou Medical University (Guiyang Medical University) - Department of Hematology

Guiyang

China

SCHOLARLY PAPERS

4

DOWNLOADS

164

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Trend of the Coronavirus Disease-2019 Epidemic in China After the Lockdown of Wuhan City on January 23, 2020

Number of pages: 33 Posted: 24 Mar 2020
Guizhou University of Traditional Chinese Medicine - Department of Science and Education, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Guizhou University of Traditional Chinese Medicine - Department of Science and Education, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Guizhou University of Traditional Chinese Medicine - Department of Science and Education, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Zunyi Medical University - Department of Pediatrics, Guizhou Center for Disease Control and Prevention - Health Monitoring and Testing Institute, Academy of Military Sciences - Institute of Radiation Medicine, Academy of Military Sciences - Institute of Radiation Medicine and Guizhou University of Traditional Chinese Medicine - Department of Science and Education
Downloads 130 (237,183)

Abstract:

Loading...

COVID-19; Inflection period; Severe case rate; Fatality rate; Recovery rate

2.

References of 'Successful Experience' of Epidemic Prevention and Control in Six Provinces of China to 'Global Epidemic'

Number of pages: 19 Posted: 14 Apr 2020
Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Guizhou University of Traditional Chinese Medicine - Department of Science and Education, Guizhou University of Traditional Chinese Medicine - Department of Science and Education, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Zunyi Medical University - Department of Pediatrics, Academy of Military Sciences - Institute of Radiation Medicine, Academy of Military Sciences - Institute of Radiation Medicine, Guizhou Center for Disease Control and Prevention - Health Monitoring and Testing Institute and Guizhou University of Traditional Chinese Medicine - Department of Science and Education
Downloads 27 (519,739)

Abstract:

Loading...

COVID-19; Prevention and control experience; Epidemic; Global outbreak; Imported cases

3.

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

Number of pages: 84 Posted: 02 Dec 2019
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Army Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Provincial People's Hospital, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Government of the People's Republic of China - Tangdu Hospital, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Government of the People's Republic of China - Sichuan Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Chengdu Military Region of the PLA, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Xinjiang Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Department of Hematology, City of Hope National Medical Center - Beckman Research Institute, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 4 (670,613)

Abstract:

Loading...

acute myeloid leukemia; high risk; allogeneic hematopoietic stem cell transplantation; decitabine; granulocyte colony-stimulating factor; relapse

4.

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

Number of pages: 84 Posted: 26 Nov 2019
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - College of Preventive Medicine, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Hematology, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Provincial People's Hospital, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Government of the People's Republic of China - Tangdu Hospital, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Government of the People's Republic of China - Sichuan Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Chengdu Military Region of the PLA, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Xinjiang Provincial People's Hospital, Government of the People's Republic of China - General Hospital of Lanzhou Military Region, Xinjiang Medical University, Government of the People's Republic of China - General Hospital of Kunming Military Region, Government of the People's Republic of China - Department of Hematology, City of Hope National Medical Center - Beckman Research Institute, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 3 (678,654)

Abstract:

Loading...

acute myeloid leukemia; high risk; allogeneic hematopoietic stem cell transplantation; decitabine; granulocyte colony-stimulating factor; relapse